Dusa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DUSA, and when can generic versions of DUSA drugs launch?
DUSA has one approved drug.
There are five US patents protecting DUSA drugs.
There are ten patent family members on DUSA drugs in three countries.
Summary for Dusa
International Patents: | 10 |
US Patents: | 5 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Patent Litigation for Dusa: | See patent lawsuits for Dusa |
Drugs and US Patents for Dusa
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dusa | LEVULAN | aminolevulinic acid hydrochloride | SOLUTION;TOPICAL | 020965-001 | Dec 3, 1999 | RX | Yes | Yes | 10,357,567 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Dusa | LEVULAN | aminolevulinic acid hydrochloride | SOLUTION;TOPICAL | 020965-001 | Dec 3, 1999 | RX | Yes | Yes | 11,571,478 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Dusa | LEVULAN | aminolevulinic acid hydrochloride | SOLUTION;TOPICAL | 020965-001 | Dec 3, 1999 | RX | Yes | Yes | 11,135,293 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Dusa | LEVULAN | aminolevulinic acid hydrochloride | SOLUTION;TOPICAL | 020965-001 | Dec 3, 1999 | RX | Yes | Yes | 11,690,914 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Dusa | LEVULAN | aminolevulinic acid hydrochloride | SOLUTION;TOPICAL | 020965-001 | Dec 3, 1999 | RX | Yes | Yes | 11,077,192 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Dusa
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Dusa | LEVULAN | aminolevulinic acid hydrochloride | SOLUTION;TOPICAL | 020965-001 | Dec 3, 1999 | 7,723,910 | ⤷ Try a Trial |
Dusa | LEVULAN | aminolevulinic acid hydrochloride | SOLUTION;TOPICAL | 020965-001 | Dec 3, 1999 | 5,422,093 | ⤷ Try a Trial |
Dusa | LEVULAN | aminolevulinic acid hydrochloride | SOLUTION;TOPICAL | 020965-001 | Dec 3, 1999 | 5,079,262 | ⤷ Try a Trial |
Dusa | LEVULAN | aminolevulinic acid hydrochloride | SOLUTION;TOPICAL | 020965-001 | Dec 3, 1999 | 6,710,066 | ⤷ Try a Trial |
Dusa | LEVULAN | aminolevulinic acid hydrochloride | SOLUTION;TOPICAL | 020965-001 | Dec 3, 1999 | 8,758,418 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Dusa Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Australia | 2020267186 | ⤷ Try a Trial |
Australia | 2019200152 | ⤷ Try a Trial |
Japan | 2019123708 | ⤷ Try a Trial |
Australia | 2022209242 | ⤷ Try a Trial |
Australia | 2021102111 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.